Peptide record

TPDB93301

Angiopep-7 Blood-Brain Barrier standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB93301
Angiopep-7
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia
standard
No
A 19-aa standard natural blood-brain barrier peptide sequence curated from B3Pred, BBPpredict, and Peptipedia, with an available 3D structural model.
C-terminal: Chemical modification N-terminal: C-terminal modification
Sequence
TFFYGGSRGRRNNFRTEEY
Physicochemical Analysis
C104H149N33O31
ADCQHILKMPWV
R
2357.53
10.24
4
2
5
+2
3.29
-1.558
0.00
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
2980
126.40
7
Residue Composition
number
0
A
4
R
2
N
0
D
0
C
2
E
0
Q
3
G
0
H
0
I
0
L
0
K
0
M
3
F
0
P
1
S
2
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 0 R: 4 N: 2 D: 0 C: 0 E: 2 Q: 0 G: 3 H: 0 I: 0 L: 0 K: 0 M: 0 F: 3 P: 0 S: 1 T: 2 W: 0 Y: 2 V: 0
Chemical Descriptors
19
C104H149N33O31
2357.53
10.24
+2
3.29
-1.558
Chemical modification
Linear
C-terminal modification
Similarity
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
Evidence Records 2 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.22 %/g

Assay & Model

Origin/Source
% injected dose

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
in situ brain perfusion
Permeability
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.032 %/g

Assay & Model

Origin/Source
% injected dose

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Direct iodination
Additional Detail Fields 1 fields
in situ brain perfusion Intravenous